Amended Current Report Filing (8-k/a)
February 17 2017 - 1:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K/A
AMENDMENT
NO. 1
CURRENT REPORT
PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of Report
(Date of earliest event reported):
December 21,
2016
ACETO CORPORATION
(Exact name of
registrant as specified in its charter)
New York
|
|
000-04217
|
|
11-1720520
|
(State or Other Jurisdiction of
Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification
No.)
|
4 Tri Harbor Court, Port
Washington, NY
|
|
11050
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(516) 627-6000
(Registrant’s
telephone number, including area code)
Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
|
¨
|
Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Explanatory Note
This current report on
Form 8-K/A (the “Amendment”) of Aceto Corporation (the “Company”) amends the current report on Form 8-K
filed on December 21, 2016 (the “Original Form 8-K”) related to the Company’s acquisition of certain generic
products and related assets of entities formerly known as Citron Pharma LLC and its affiliate Lucid Pharma LLC. This Amendment
includes the pro forma financial information required by Item 9.01(b) of Form 8-K, and does not amend or otherwise update any other
information in the Original Form 8-K. Accordingly, this Amendment should be read in conjunction with the Original Form 8-K.
|
Item 9.01
|
Financial Statements and Exhibits.
|
(b) Pro Forma Financial Information
The unaudited pro forma
financial information is included as Exhibit 99.1 to this Amendment and is incorporated herein by reference.
(d) Exhibits:
Exhibit No.
|
|
Document
|
99.1
|
|
Pro Forma Information
|
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
ACETO CORPORATION
|
|
|
|
|
|
|
Dated: February 17, 2017
|
By:
|
/s/ Salvatore Guccione
|
|
Name:
|
Salvatore Guccione
|
|
Title:
|
President and Chief Executive Officer
|
EXHIBIT INDEX
Exhibit No.
|
|
Document
|
99.1
|
|
Pro Forma Information
|